Corvex, Inc. Form 4 Filings

Corvex, Inc. director and Co‑CEO Crystal John Adler III reported automatic conversions of Series C preferred stock into common stock of MOVE. On July 7, 2026, 3,345.5239 shares of Series C Non‑Voting Convertible Preferred Stock converted into 3,345,523 shares of common stock, and 708.1544 Series C shares held through the John Adler Crystal III Roth IRA converted into 708,154 common shares, all at a 1‑to‑1,000 conversion ratio. Following these conversions, Adler holds 6,414,723 common shares directly and 711,321 common shares indirectly through the Roth IRA, and no Series C Preferred Stock remains outstanding in these positions.

Corvex, Inc. director Emily Fairbairn reported an automatic conversion of preferred stock into common shares held through affiliated entities. On July 7, 2026, 1,205.2825 shares of Series C Non-Voting Convertible Preferred Stock converted into 1,205,282 common shares at a 1-to-1,000 ratio.

The converted shares, together with existing holdings, are owned indirectly through Moira Partners, a charitable remainder unitrust, and Valley High Limited Partnership, plus 228,577 shares held directly. Fairbairn has voting and investment power over these entities but disclaims beneficial ownership beyond her pecuniary interest.

Corvex, Inc. director Emily Fairbairn reported new equity awards and a preferred stock exchange. She received 135,800 time-based restricted stock units in Common Stock that vest in three equal annual installments, bringing her directly held common shares to 228,577.

Separately, an entity associated with her, Moira Partners, LLC, exchanged 858.5403 shares of Series C Preferred Stock for 858.5403 shares of Series D Preferred Stock on a one-for-one basis under an Exchange Agreement. Both series are perpetual and each share converts into 1,000 shares of Common Stock, with Series C scheduled to convert on July 7, 2026 and Series D convertible upon delivery of a conversion notice.

Corvex, Inc. reported that CFO Christopher Moreland received an equity grant of 523,211 shares of Common Stock on July 1, 2026. The Form 4 classifies this as a grant or award acquisition at a stated price of $0.00 per share, reflecting compensation rather than a market purchase.

According to the footnote, these shares are time-based restricted stock units that vest in four equal annual installments from the grant date. After this award, Moreland directly holds 523,211 shares, and the filing shows no open-market buys or sells and no remaining derivative positions.

Corvex, Inc. director Patrick Fleury reported equity awards that increase his stake in the company. He received 100,000 shares of common stock as a grant, structured as time-based restricted stock units that vest in three equal annual installments from the grant date.

He was also granted stock options for 200,000 shares of common stock at an exercise price of $21.06 per share, expiring on July 1, 2036. These options vest in three equal annual installments from the grant date. After these awards, his reported direct holdings are 100,000 shares and options on 200,000 shares.

DONOFRIO NICHOLAS M reported acquisition or exercise transactions in this Form 4 filing.

Corvex, Inc. director Nicholas M. Donofrio received an equity grant of 50,000 shares of Common Stock in the form of restricted stock units. The Form 4 shows this as an award transaction with no cash price per share.

The footnote explains these are time-based restricted stock units that vest in three equal annual installments starting from the grant date. Following this grant, Donofrio holds 50,000 shares directly, indicating this is a new equity-based compensation award rather than an open-market purchase or sale.

Cullinan Brian reported acquisition or exercise transactions in this Form 4 filing.

Corvex, Inc. director Brian Cullinan received a grant of 50,000 shares of Common Stock in the form of time-based restricted stock units. These RSUs vest in three equal annual installments from the grant date, meaning the shares are earned over three years as service continues. Following this award, Cullinan directly holds 111,276 shares of Corvex common stock. This is a compensation-related equity grant rather than an open-market purchase or sale.

Corvex, Inc. director Brian Cullinan exercised stock options to acquire 48,209 shares of Common Stock at an exercise price of $0.92 per share. These newly acquired shares increased his direct Common Stock holdings to 61,276 shares following the transaction. The exercised options, covering 48,209 shares, were fully converted into Common Stock and now have a reported post-transaction balance of zero. The filing notes that both the number of shares and the option exercise price were adjusted to reflect a prior stock dividend, where each share of Common Stock was automatically converted into 1.358 shares and distributed in early April 2026.

Corvex, Inc. director Ruben Caballero exercised stock options to acquire 29,197 shares of Common Stock at an exercise price of $0.92 per share. Following this derivative exercise, his direct holdings increased to 38,017 Common shares. The filing notes that both the share amounts and exercise price reflect adjustments from a prior stock dividend and were tied to an option award under the company’s Omnibus Incentive Plan.

Corvex, Inc. director Seth Demsey reported automatic conversions of Series B Preferred Stock into Common Stock on March 31, 2026. The filing shows 24.5327 shares of Series B Preferred Stock converting into 24,532 shares of Common Stock held directly, and 0.1399 preferred shares converting into 139 common shares held indirectly.

After the transactions, Demsey directly holds 3,078,767 shares of Common Stock. The indirect Common Stock is held through Ainsworth Holdings, LLC, where Demsey is the managing member and has sole voting and dispositive power but disclaims beneficial ownership except for his pecuniary interest. The Series B Preferred Stock converts at a 1-to-1,000 ratio and is perpetual with no expiration date.

Corvex, Inc. Chief Executive Officer Crystal John Adler III reported automatic conversions of Series B Preferred Stock into common stock on March 31, 2026. A total of 14.9652 shares of Series B Preferred Stock converted into 14,965 shares of common stock held directly, bringing his direct common stock holdings to 3,069,200 shares, which include unvested restricted stock units. An additional 3.1677 shares of Series B Preferred Stock converted into 3,167 shares of common stock held indirectly in the John Adler Crystal III Roth IRA, an account over which he has sole voting and dispositive power while disclaiming beneficial ownership beyond his pecuniary interest.

Corvex, Inc. director Emily Fairbairn reported a conversion of preferred stock into common shares. On March 31, 2026, 9.2319 shares of Series B Convertible Preferred Stock automatically converted into 9,231 shares of common stock at a 1-to-1,000 conversion ratio, with fractional shares paid in cash.

The new common shares are held indirectly through affiliated entities where Fairbairn has voting and investment power, and she disclaims beneficial ownership beyond her pecuniary interest. Following these transactions, she holds 68,369 common shares directly and additional indirect holdings of 22,232 and 3,522 common shares through separate entities.

Movano Inc. director Emily Fairbairn reported three acquisitions of derivative securities. She received Series B Preferred Stock that automatically converts into common stock on March 31, 2026 at a 1-for-1000 ratio, and perpetual Series C Preferred Stock that will convert at a 1-for-1000 ratio upon stockholder approval under Nasdaq rules.

These preferred shares were received in exchange for her Corvex, Inc. equity in connection with a merger agreement. She also received a stock option for 200,000 shares of common stock at an exercise price of $15.09 per share, vesting in three equal annual installments and becoming exercisable only after shareholder approval of the award.

Cogan Jeremy reported acquisition or exercise transactions in this Form 4 filing.

Movano Inc. CFO Jeremy Cogan reported an equity compensation grant rather than an open-market trade. He received 37,000 shares of Common Stock on March 18, 2026, reflecting a grant of restricted stock units under the company’s Omnibus Incentive Plan. After this award, his direct holdings total 97,504 shares of Movano Inc. common stock. This filing records routine executive compensation and does not indicate a discretionary stock purchase or sale.

Movano Inc. director Wirk Shaheen exercised stock options to acquire 10,000 shares of Common Stock on March 13, 2026 at an exercise price of $1.25 per share. The options related to an award that became exercisable after shareholders approved an amendment to the Omnibus Incentive Plan on December 16, 2025. Following the transaction, Shaheen directly holds 15,960 shares of Movano Common Stock.

Movano Inc. director Emily Fairbairn exercised stock options for 55,250 shares of Common Stock at an exercise price of $1.25 per share. The options were previously granted contingent on shareholder approval of an amendment to the Omnibus Incentive Plan and became exercisable after approval on December 16, 2025.

Following the exercise on March 16, 2026, she holds 68,369 shares of Common Stock directly. Additional Common Stock is held indirectly through the Fairbairn Unitrust and Valley High Limited Partnership, where she has voting and investment power, while disclaiming beneficial ownership in the trust except for her and her spouse’s pecuniary interest.

Movano Inc. Chief Executive Officer and Director John Mastrototaro reported exercising stock options and related share sales. On January 26, 2026, he exercised 72,834 stock options at an exercise price of $1.25 per share, receiving the same number of common shares.

On January 27, 2026, he sold several blocks of Movano common stock, including 4,512 shares at a weighted average of $19.12, 5,444 shares at $20.18, 14,960 shares at $20.75, 5,746 shares at $21.78, and 2,407 shares at $23.37. A footnote states these sales were made to pay withholding taxes and exercise prices tied to stock option awards granted in lieu of 2025 cash salary. After the transactions, he directly owned 56,114 Movano common shares.

The option exercised was granted contingent on shareholder approval of an amendment to Movano’s Omnibus Incentive Plan increasing authorized shares; it became exercisable upon shareholder approval of the Plan Amendment on December 16, 2025.

Movano Inc. CFO Jeremy Cogan reported an option exercise and related share sales. On January 26, 2026, he exercised 64,834 stock options at an exercise price of $1.25 per share, receiving the same number of common shares.

On January 27, 2026, he sold an aggregate of 28,736 common shares in multiple open-market transactions at weighted average prices between $19.11 and $23.37. A footnote states these sales were made to pay withholding taxes and exercise prices tied to option awards granted in lieu of 2025 cash salary. After these transactions, he directly owned 60,504 Movano common shares.

Movano Inc.'s Chief Technology Officer Michael Aaron Leabman received 11,174 shares of common stock on January 9, 2026 through a grant of restricted stock units. The RSUs were issued under the company’s Omnibus Incentive Plan in lieu of cash salary for the period from January 1, 2026 to March 31, 2026, so no cash was paid per share. Following this grant, Leabman directly beneficially owned 33,813 shares of Movano common stock.

Movano Inc.'s chief technology officer and director Michael Aaron Leabman reported selling blocks of common stock in three transactions. On January 12, 2026, he sold 3,377 shares at a weighted average price of $7.01, followed by 2,076 shares at $6.94 on January 13 and 6,845 shares at $6.66 on January 14. The filing states these shares were sold to pay withholding taxes and exercise prices tied to stock option awards granted in lieu of cash salary during 2025. After these sales, he directly holds 22,639 Movano common shares.

Movano Inc. (MOVE) filed an insider trading report showing its Chief Executive Officer and director, John Mastrototaro, receiving additional equity compensation. On January 9, 2026, he was granted 11,919 shares of common stock at a price of $0.00 per share, reported as a receipt of restricted stock units under the company’s Omnibus Incentive Plan. The grant was made in lieu of cash salary for the period from January 1, 2026 to March 31, 2026. Following this award, Mastrototaro beneficially owned 16,349 shares of Movano common stock, held directly.

Movano Inc. director Emily Fairbairn reported equity compensation and holdings in company stock. On January 9, 2026, she received grants of 4,470 restricted stock units (RSUs) under the company’s Omnibus Incentive Plan in lieu of cash directors’ fees for the period from January 1, 2026 to June 30, 2026, and a separate grant of 5,959 RSUs for the same period. Both grants were reported at a price of $0 per share, reflecting that they are non-cash awards.

Following these awards, Fairbairn reported 13,119 shares of Movano common stock held directly. She also reported indirect holdings of 33,232 shares held by the Malcolm P. Fairbairn and Emily T. Fairbairn Charitable Remainder Unitrust, over which she has voting and investment power while disclaiming beneficial ownership except for her and her spouse’s pecuniary interest, and 3,522 shares held by Valley High Limited Partnership, over which she also has voting and investment power.

Movano Inc. director Brian Cullinan reported stock-based compensation. On January 9, 2026, he received two grants tied to service under the company’s Omnibus Incentive Plan for the period from January 1, 2026 to June 30, 2026.

The filing shows a grant of 4,768 restricted stock units (RSUs) in lieu of cash directors’ fees for that period, and a separate grant of 2,980 RSUs for the same service period. Both entries are recorded at a price of $0.00 per share. After these awards, Cullinan is shown as beneficially owning 9,622 shares of Movano common stock, held directly.

Movano Inc. director Ruben Caballero reported receiving equity compensation instead of cash fees. On January 9, 2026, he acquired 2,980 shares of common stock at $0 per share, with the footnote explaining this reflects a grant of 2,980 restricted stock units (RSUs) under the Omnibus Incentive Plan in lieu of cash directors’ fees for the period from January 1, 2026 to June 30, 2026. A second transaction that same day reports another acquisition of 2,980 shares at $0 per share, tied to a separate grant of 2,980 RSUs for the same period. Following these grants, Caballero beneficially owned 6,495 shares of Movano common stock directly.

Movano Inc. director Shaheen Wirk reported stock-based compensation rather than a cash payment. On January 9, 2026, Wirk received a grant of 2,980 restricted stock units (RSUs) under Movano’s Omnibus Incentive Plan in lieu of cash directors’ fees for the period from January 1, 2026 to June 30, 2026. On the same date, Wirk received a separate grant of 2,980 RSUs under the same plan for service over that same January 1, 2026 to June 30, 2026 period.

Both transactions are reported at a price of $0 per share, reflecting equity compensation rather than a market purchase. Following these grants, Wirk is shown as beneficially owning 5,860 shares of Movano common stock directly.

Movano Inc. director and Chief Technology Officer Michael Aaron Leabman reported exercising stock options and related share sales. On January 6, 2026, he exercised 42,250 stock options at an exercise price of $1.25 per share, receiving the same number of Movano common shares. On January 7, 8, and 9, 2026, he sold 3,293, 3,593, and 783 shares, respectively, at weighted average prices of $7.34, $7.26, and $7.27 per share, with the filing noting that shares were sold to pay withholding taxes and exercise costs tied to option awards received in lieu of 2025 cash salary. After these transactions, Leabman directly held 34,937 shares of Movano common stock. The filing also states that the option award became exercisable following shareholder approval of an amendment to the Omnibus Incentive Plan on December 16, 2025.

Movano Inc. CFO Jeremy Cogan reported several equity transactions. On January 5, 2026, he exercised 20,000 stock options at an exercise price of $1.25 per share, converting them into common stock. That same day, he sold 1,879 common shares at a weighted average price of $8.35, with actual prices ranging from $8.00 to $8.61, to cover withholding taxes and exercise costs tied to option awards received in lieu of 2025 cash salary.

On January 6, 2026, he sold 3,859 shares at a weighted average price of $8.03 and 4,359 shares at a weighted average price of $7.57, also in multiple trades within stated price ranges for tax and exercise obligations. On January 9, 2026, he received a grant of 9,299 restricted stock units (RSUs) in lieu of salary for the period from January 1, 2026 to March 31, 2026. After these transactions, he directly owned 24,406 shares of common stock and held 64,834 stock options.

Movano Inc. reported an insider transaction by Chief Executive Officer and director John Mastrototaro on January 5, 2026. He exercised 5,000 stock options with a $1.25 exercise price, receiving 5,000 shares of common stock. On the same day, he sold 2,514 common shares at $8.21 per share to cover withholding taxes and exercise costs related to stock option awards granted in lieu of cash salary during 2025.

Following these transactions, Mastrototaro directly owned 4,430 shares of Movano common stock and 72,834 stock options. The option exercised on January 5, 2026 had been granted contingent on shareholder approval of an amendment to the Omnibus Incentive Plan, which was approved on December 16, 2025, making the option exercisable.

Movano Inc. (MOVE) reported an insider equity change. On 11/03/2025, a director forfeited 12,442 previously awarded RSUs in lieu of directors’ fees and received a stock option for 55,250 shares at an exercise price of $1.25.

The option will become exercisable upon shareholder approval of an amendment increasing shares under the Omnibus Incentive Plan. Following the transactions, the director beneficially owned 2,690 common shares. The disclosed option lists an expiration date of 12/31/2025.

Movano Inc. (MOVE) director Form 4: On 11/03/2025, a director forfeited 8,295 restricted stock units in lieu of directors’ fees and received a stock option grant covering 21,500 shares of Common Stock at an exercise price of $1.25 per share. The option is contingent on shareholder approval of an amendment to the Omnibus Incentive Plan and will become exercisable upon that approval. The option shows an expiration date of 12/31/2025 and was reported as directly owned.

Movano Inc. (MOVE) reported an insider equity change. On 11/03/2025, a director forfeited 6,841 restricted stock units in lieu of directors’ fees and received a grant of stock options for 10,000 shares at an exercise price of $1.25.

The options will become exercisable upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases the shares authorized for issuance. Following the transactions, non-derivative common stock beneficially owned was 0 shares, and derivative holdings were 10,000 options, held directly.

Movano Inc. (MOVE) reported an insider equity adjustment by its Chief Executive Officer and Director. On 11/03/2025, the officer forfeited 39,226 RSUs in lieu of salary and received a grant of 77,834 stock options with an exercise price of $1.25. The filing states these options were granted contingent upon shareholder approval of an amendment increasing shares under the Omnibus Incentive Plan, and will become exercisable upon that approval. Following the transactions, the officer reported 1,944 shares beneficially owned.

Movano Inc. (MOVE) reported an insider transaction on a Form 4. A director and Chief Technology Officer forfeited previously awarded RSUs in lieu of salary and received a stock option grant. On 11/03/2025, the insider disposed of 21,260 shares at a reported price of $0. Following the transaction, the insider directly owned 356 shares of common stock.

Concurrently, the insider was granted 42,250 stock options with an exercise price of $1.25 per share. The grant is contingent upon shareholder approval of an amendment to the Omnibus Incentive Plan, and the option will become exercisable upon that approval. The option carries an expiration date of 12/31/2025.

Movano Inc. (MOVE) disclosed a Form 4 for its CFO, reporting a compensation adjustment on 11/03/2025. The executive forfeited 31,871 restricted stock units at a $0 price in lieu of salary and received a grant of stock options for 84,834 shares with a $1.25 exercise price.

The option becomes exercisable only upon shareholder approval of an amendment to the Omnibus Incentive Plan that increases shares authorized for issuance. The option carries an expiration date of 12/31/2025. Following the transaction, the executive beneficially owned 5,204 shares of common stock directly.

Movano (MOVE) reported an insider compensation change. On 11/03/2025, a director forfeited 13,271 RSUs previously awarded under the Omnibus Incentive Plan, in lieu of directors’ fees, and received a grant of stock options for 35,500 shares at an exercise price of $1.25.

The option award was contingent upon shareholder approval of an amendment to increase shares authorized under the plan; the options will become exercisable upon that approval. After the transaction, the director beneficially owned 1,874 shares of common stock directly.

Movano Inc. director Emily Fairbairn received a grant of 31,028 restricted stock units (RSUs) on 10/03/2025 as payment in lieu of directors' fees for the period 10/01/2025 to 12/31/2025 The RSUs were granted under the company's Omnibus Incentive Plan at no cash price to the reporting person. After the grant the filing reports a total of 151,315 RSUs beneficially owned by the reporting person. The Form 4 was signed via attorney-in-fact on 10/08/2025.

The filing documents a routine equity-based compensation transaction for a director rather than an open-market sale or purchase. The award replaces cash fees with equity, increasing the reporting person's holdings and aligning compensation with share ownership while not showing any cash consideration in the reported transaction.

Movano Inc. director Wirk Shaheen received a grant of 20,685 restricted stock units (RSUs) under the company's Omnibus Incentive Plan as payment in lieu of directors' fees for the period 10/01/2025 to 12/31/2025. The transaction date reported is 10/03/2025 and shows a $0 per‑unit price for the award. Following the reported grant the reporting person beneficially owns 68,412 RSUs. The Form 4 was signed on 10/07/2025 by an attorney‑in‑fact.

Movano Inc. director Brian Cullinan received a grant of 33,096 restricted stock units (RSUs) on 10/03/2025 that were issued in lieu of directors' fees for the period October 1, 2025 to December 31, 2025. The RSUs carry a reported price of $0 and the filing shows 151,452 RSUs or shares beneficially owned by the reporting person following the award. The Form 4 was signed on 10/07/2025 by an attorney-in-fact.

The transaction is recorded as an award under the company's Omnibus Incentive Plan and increases the director's reported beneficial ownership. No cash purchase or sale price is reported because these RSUs were granted in lieu of cash fees.

Movano Inc. director Ruben Caballero received a grant of 20,685 restricted stock units (RSUs) under the company Omnibus Incentive Plan in lieu of directors' fees for the period 10/01/2025 to 12/31/2025. The Form 4 reports the award was executed on 10/03/2025 and the RSUs carry a reported price of $0, indicating a fee-equivalent grant rather than a cash payment. Following this grant the filing shows 88,294 RSUs beneficially owned by the reporting person, with ownership reported as direct. The form was signed on 10/07/2025 by an attorney-in-fact on behalf of the reporting person.

Movano Inc. director and Chief Executive Officer John Mastrototaro received a grant of 165,484 restricted stock units (RSUs) on 10/03/2025 that were issued in lieu of salary for the period 10/01/2025 to 12/31/2025. The new award increases his total reported beneficial ownership of the company's common stock to 411,705 shares. The RSUs were recorded at an exercise/transaction price of $0, indicating they are equity awards rather than purchases. The Form 4 was filed by one reporting person and signed on 10/07/2025.

This disclosure shows executive compensation was partly paid in equity for the stated quarter, which directly increases insider holdings and aligns pay with shareholder equity rather than cash salary for the specified period.

Jeremy Cogan, Chief Financial Officer and a director of Movano Inc. (MOVE), reported a grant of 134,456 restricted stock units (RSUs) received on 10/03/2025 under the companyOmnibus Incentive Plan in lieu of salary for the period 10/01/2025 to 12/31/2025. The Form 4 shows the RSUs were issued at a $0 per-share price and that the total number of shares/RSUs beneficially owned following the transaction is 370,756, with the reported RSUs comprising the amount shown. The filing is signed on 10/07/2025 by an attorney-in-fact on behalf of the reporting person.